Neurocrine Biosciences (NBIX) Receivables - Other (2019 - 2025)
Neurocrine Biosciences (NBIX) posted quarterly Receivables - Other of $20.5 million for Q4 2025, up 42.36% year-over-year from $14.4 million in Q4 2024, and up 42.36% on a QoQ basis from $14.4 million in Q4 2024.
Neurocrine Biosciences (NBIX) Receivables - Other (2019 - 2025) Analysis & Trends
Neurocrine Biosciences has reported Receivables - Other for 7 years, with the latest figure at $20.5 million in Q4 2025.
- Receivables - Other for Q4 2025 came in at $20.5 million, up 42.36% year-over-year; the trailing twelve-month figure through Dec 2025 was $20.5 million (up 42.36% YoY), and the FY2025 annual result was $20.5 million, up 42.36% from the prior year.
- Receivables - Other climbed to $20.5 million in Q4 2025, from $14.4 million in the prior quarter.
- Over five years, Receivables - Other peaked at $20.5 million in Q4 2025 and troughed at $2.2 million in Q4 2021.
- A 5-year average of $6.8 million and a median of $4.4 million in 2023 frame the typical range for Receivables - Other.
- The widest annual swing landed in 2021, when Receivables - Other plunged 40.54%; it then jumped 186.36% in 2024.
- A 5-year view of Receivables - Other shows it stood at $2.2 million in 2021, then soared by 113.64% to $4.7 million in 2022, then surged by 138.3% to $11.2 million in 2023, then gained by 28.57% to $14.4 million in 2024, then soared by 42.36% to $20.5 million in 2025.
- Per Business Quant data, the three most recent Receivables - Other figures were $20.5 million in Q4 2025, $14.4 million in Q4 2024, and $12.6 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.50 Mn |
| Dec 31, 2025 | 20.50 Mn |
| Dec 31, 2024 | 14.40 Mn |
| Dec 31, 2024 | 14.40 Mn |
| Mar 31, 2024 | 12.60 Mn |
| Mar 31, 2024 | 12.60 Mn |
| Dec 31, 2023 | 11.20 Mn |
| Dec 31, 2023 | 11.20 Mn |
| Sep 30, 2023 | 8.10 Mn |
| Sep 30, 2023 | 8.10 Mn |
| Jun 30, 2023 | 5.60 Mn |
| Jun 30, 2023 | 5.60 Mn |
| Mar 31, 2023 | 4.40 Mn |
| Mar 31, 2023 | 4.40 Mn |
| Dec 31, 2022 | 4.70 Mn |
| Dec 31, 2022 | 4.70 Mn |
| Sep 30, 2022 | 3.90 Mn |
| Sep 30, 2022 | 3.90 Mn |
| Jun 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 2.70 Mn |